Skip to main content
logo
Boditech Med Inc. (KOSDAQ:206640)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,750.00
+50.00 (0.52%)
Oct 2, 2026, 3:30 PM KST

Boditech Med Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
25,95023,65327,26025,94724,15244,367
Depreciation & Amortization
10,04410,0628,4428,2327,4736,041
Loss (Gain) From Sale of Assets
73.8513.6648.52-317.25-43.6286.54
Asset Writedown & Restructuring Costs
519.24519.24--35.8679.44
Loss (Gain) From Sale of Investments
-570.91-226.04-563.78-415.34-59.8763.47
Loss (Gain) on Equity Investments
1,3901,452497.31113.95390.07407.01
Stock-Based Compensation
-84.16-130.88-66.32221.53110.3656.51
Provision & Write-off of Bad Debts
1,719345.36472.512,587638.814,689
Other Operating Activities
-1,074-1,509-2,8624,161-4,804-660.03
Change in Accounts Receivable
-15,211-9,778-3,070-10,4872,1844,914
Change in Inventory
-11,642-4,240-7,879-2,001-896.01-9,330
Change in Accounts Payable
2,950233.98865.456,027-5,446843.28
Change in Other Net Operating Assets
754.441,6871,733231.81-664.24-1,629
Operating Cash Flow
14,81922,08124,87934,30023,06849,927
Operating Cash Flow Growth
-41.23%-11.24%-27.47%48.69%-53.80%11.84%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-35,398-33,013-11,427-4,605-15,260-18,230
Sale of Property, Plant & Equipment
500.7349.751,433174.6312.74182.5
Cash Acquisitions
-259.72-259.72----
Divestitures
---181.79-248.48
Sale (Purchase) of Intangibles
-708.6-1,007-1,041-1,025-1,595-181.71
Investment in Securities
13,540-14,492-890.91-10,944-7,5922,220
Other Investing Activities
420.56420.56-51.9695.61-320.35157.44
Investing Cash Flow
-21,905-48,301-11,978-16,122-24,454-15,603

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-20,33116,30215,8724,884800
Long-Term Debt Repaid
--14,923-18,009-14,739-3,698-7,033
Net Debt Issued (Repaid)
9,0875,409-1,7061,1331,186-6,233
Issuance of Common Stock
3,52512.3135.312.3141.824.68
Repurchase of Common Stock
-4,990-4,977-2,964--7,219-8,750
Dividends Paid
-3,256-3,267-4,395-3,295-4,270-4,609
Other Financing Activities
201,040954.36212.23-0-369.26
Financing Cash Flow
4,385-1,784-7,976-1,938-10,162-19,937

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
232.82-384.83525.64-7.28-1,008383.97
Net Cash Flow
-2,468-28,3885,45016,232-12,55514,772

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-20,580-10,93213,45229,6957,80831,697
Free Cash Flow Growth
---54.70%280.32%-75.37%-21.86%
Free Cash Flow Margin
-11.77%-6.74%9.74%22.12%6.61%20.10%
Free Cash Flow Per Share
-951.50-504.42612.871351.72349.131383.14
Levered Free Cash Flow
-32,862-18,337583.7123,582-530.4617,557
Unlevered Free Cash Flow
-32,509-18,080804.0323,801-403.0117,680

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
584.12359.83340.04336.8264.63158.79
Cash Income Tax Paid
3,6316,5786,1902,6728,03611,879
Change in Working Capital
-23,147-12,097-8,350-6,229-4,823-5,202